Related Experiment Video
Updated: Feb 28, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Ru-Based NSAIDs as Potential Anticancer Therapeutics
Silvia Bordoni1, Magda Monari2, Carla Boga1
1Department of Industrial Chemistry 'Toso Montanari', Alma Mater Studiorum, Università di Bologna, Via Piero Gobetti, 85, 40129 Bologna, Italy.
Novel ruthenium complexes were synthesized using non-steroidal anti-inflammatory drugs (NSAIDs) as ligands. One NSAID-ruthenium complex demonstrated significant antiproliferative effects against cancer cells, highlighting potential for new metallotherapeutics.
Area of Science:
- Inorganic Chemistry
- Medicinal Chemistry
- Materials Science
Background:
- Metal-based drugs offer enhanced bioactivity by incorporating existing pharmaceuticals as ligands.
- Ruthenium complexes are explored for therapeutic applications, particularly in oncology.
Purpose of the Study:
- To synthesize novel ruthenium(II) complexes utilizing non-steroidal anti-inflammatory drugs (NSAIDs) as ligands.
- To investigate the structural and preliminary biological properties of these new metallodrugs.
Main Methods:
- Synthesis of neutral κ²-(O,O)-chelate ruthenium complexes by substituting ligands in [Ru(H)₂(CO)(PPh₃)₃].
- Characterization using single-crystal X-ray diffraction (SCXRD) for selected complexes.
- Preliminary biological evaluation of antiproliferative activity against cancer cell lines.
Main Results:
- Five novel ruthenium-NSAID complexes were successfully synthesized, releasing molecular hydrogen.
- Complexes with diclofenac and aspirin were structurally characterized by SCXRD.
- Ruthenium-salicylic acid complex (2) exhibited promising antiproliferative activity against HeLa cancer cells.
Conclusions:
- NSAID-ruthenium(II) complexes represent a viable platform for developing novel anticancer metallotherapeutics.
- The synthesized complexes show potential for further investigation in drug discovery and development.
- Ruthenium complexes incorporating NSAIDs warrant further study for their therapeutic applications.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
08:56Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Abnormal Proliferation